Hammond Janet MJ — SEC Form 4 filings

SEC reporting owner CIK 1829899. 3 Form 4 filings on record with FilingPulse; latest filed 2026-02-03.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-02-02 to 2026-02-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Atea Pharmaceuticals, Inc. (AVIR)Chief Development Officer31 leg · 14,029 sh · $53,91314

Form 4 filings — Hammond Janet MJ

FiledFormIssuerReported transactionsSource
2026-02-034Atea Pharmaceuticals, Inc. (AVIR)Option exercise (M): 58,050 · Tax withholding (F): 14,136 @ $4.24 · Option exercise (M): 46,800 (derivative) @ $0 · Option exercise (M): 11,250 (derivative) @ $0 · Grant/award (A): 177,000 (derivative) @ $0EDGAR
2025-02-044Atea Pharmaceuticals, Inc. (AVIR)Option exercise (M): 46,800 · Grant/award (A): 11,250 · Tax withholding (F): 14,134 @ $3.06 · Option exercise (M): 46,800 (derivative) @ $0 · Grant/award (A): 11,250 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2024-02-024Atea Pharmaceuticals, Inc. (AVIR)Option exercise (M): 46,800 · Sale (S): 14,029 @ $3.84 · Option exercise (M): 46,800 (derivative) @ $0 · Grant/award (A): 225,200 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1829899 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →